ABCDx

ABCDx revolutionizes stroke diagnostics combining proprietary biomarkers and Artificial Intelligence. Based in Switzerland and Spain, at ABCDx we are committed developing innovative, quick, and reliable products that provide accurate disease probability assessments, aiding clinicians in making informed decisions swiftly. Our technology is designed to enhance patient care, improve outcomes, and support healthcare professionals in delivering excellence for every single patient.

ABCDx specializes in the discovery, clinical validation and commercialization of brain mobile diagnostic solutions with advanced blood-based biomarkers through it proprietary Software as a Medical Device platform.